Page results
-
A directory of resources giving advice and support to help people to manage the impact of cancer and blood conditions.
-
Advice about available financial support and how to apply for it.
-
A programme of wellbeing classes, workshops and courses. It includes activities which give advice and/or support to help people to manage the physical and emotional impact of cancer or a blood condition.
-
The main aim of second line dietary advice is to provide practical ways to relax dietary restrictions following first line advice.
-
Dr Tim Yates has a particular interest in the management of refractory headache disorders, particularly chronic migraine, the trigeminal autonomic cephalalgias, and facial pain syndromes.
-
Information for new neuro-otology patients
-
The Freedom of Information Act 2000 (FOIA) came into force on 1 January 2005 giving members of the public certain rights to ask public authorities for information relating to the public authority.
-
Virtual Multidisciplinary meetings for patients with a neuroscience condition who live in Barnet, Camden, Enfield, Haringey and Islington
-
Individuals are able to access their own. In some cases certain third parties have the right to ask for copies of medical records.
-
Initial results suggest the treatment has the potential to alter the course of the disease.
File results
-
FOI/2023/0251 - Vials used for immunoglobulin drugs - January to March 2023
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0270 - Total agency spend and midwifery spend from 2018/19 to 2022/23
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology